Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • bioinfosm
    Senior Member
    • Jan 2008
    • 483

    #1

    unique reads for downstream analysis

    I had a general query with short fixed length reads. Though I intend it for Solexa data only, it might be directly applicable to solid as well

    For analysis after obtaining the set of reads, do people prefer taking a unique non redundant set of reads, before doing analysis like snp discovery, chip-seq, etc? Are the exactly same reads any information?

    for de novo assembly, velvet behaves slightly different with a unique set of reads, than with some of the reads repeated.
    --
    bioinfosm
  • xwu
    Member
    • Dec 2007
    • 10

    #2
    I have similar question. I have seen people mentioning to remove redundant reads for chip-seq to minimize the risk of amplification bias. I tried it, and it certainly impact the peak finding a lot. I guess you should not take unique reads for RNA-seq or small RNA-seq. I will be glad to hear what other people's experience and comment about it.

    Comment

    • Annette
      Junior Member
      • May 2009
      • 3

      #3
      I can imagine that the answer depends on the project.
      If in a low coverage sequencing project I have many reads starting at the same position this would suggest PCR duplicates, especially for paired-end reads (assuming that PE duplicates are those for which both reads are exactly duplicated).

      A highly expressed short gene in RNA-seq, on the other hand, will have many reads that start at the same position without them being PCR duplicates.
      Just removing them would then lead to an underestimate of expression level.

      The recent Sanger paper (Kozarewa et al.) calculated expected duplicate frequencies based on average coverage and read length for whole genome sequencing.
      This makes sense, but I think only if you have an even distribution of coverage across the genome.
      If something like mtDNA is present that has excess coverage I could get an overestimate of duplicate frequency if I assume they are all due to amplification bias.

      So, yes, if it were easy to distinguish between duplicates due to high coverage and PCR duplicates, it might be preferable to eliminate them, at least for SNPs, RNA-Seq where counts matter...

      But again, for example in RNA-seq, how to distinguish between duplicates due to high coverage and PCR duplicates ? Maybe calculating an expected duplicate frequency like the Sanger paper but on a gene by gene basis ?

      May I ask what you mean by "velvet behaves slightly different" ?

      Comment

      • bioinfosm
        Senior Member
        • Jan 2008
        • 483

        #4
        Thanks for the notes.

        Velvet does de novo sequencing and gives different results if you input a non-redundant set of reads, than using all the reads as input
        Another de novo tool edena produces a non redundant set of reads before it proceeds with the de novo assembly...
        --
        bioinfosm

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Today, 07:41 AM
        0 responses
        9 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-03-2026, 10:13 AM
        0 responses
        24 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        38 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Working...